Treating SR-cGVHD

Dive into an immersive and engaging learning experience that covers the latest clinical data for targeted therapies, provides expert guidance on integrating them into patient specific treatment plans, including sequencing strategies to maximize outcomes and long-term management with the goal of improving quality of life; ameliorating symptoms; and reducing mortality rates. Learners will have the opportunity to explore key differences in the mechanisms that approved therapies for SR-cGVHD employ to target the inflammatory and fibrotic pathophysiological presentations that drive this condition and impair patient health. These insights will help guide clinicians with effective treatment selection and sequencing.